# A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

Source: https://onco.cc/trials/nct06984861/  
OnCo record `nct06984861` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of F-MISO (JBS-003) run by Memorial Sloan Kettering Cancer Center, now recruiting.

## Summary

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer is a phase 2 interventional study registered as NCT06984861 by Memorial Sloan Kettering Cancer Center, with 74 participants planned, started 2025-05-13. Conditions recorded: Oropharyngeal Carcinoma. Interventions recorded: 18F-FMISO PET/CT Scan, Chemoradiation and Questionnaires.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06984861
- Phase: 2
- Setting: Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma
- Sponsor: Memorial Sloan Kettering Cancer Center
- Enrolled: 74

## Sources

- ClinicalTrials.gov NCT06984861: https://clinicaltrials.gov/study/NCT06984861

## Connected records

- cancers: [Oropharyngeal cancer (tonsil and base of tongue)](https://onco.cc/cancers/oropharyngeal-cancer/)
- drugs: [F-MISO (JBS-003)](https://onco.cc/drugs/jbs-003/)
- companies: [Juniper Biosciences](https://onco.cc/companies/juniper-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct06984861.json